TP53 and prostate carcinoma: Additionally, the tumor samples with elevated HCP5 expression downregulated miRNA targets in ECM and membrane receptors, metastatic brain tumors, as well as and miRNA regulation of the p53 pathway in prostate cancer (Figure 6E).